ClinicalTrials.Veeva

Menu

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

Columbia University logo

Columbia University

Status

Active, not recruiting

Conditions

COVID-19
Vaccination Hesitancy
Influenza

Treatments

Behavioral: Text message influenza vaccine reminders
Behavioral: Text message influenza and COVID-19 vaccine reminders
Behavioral: Text message COVID-19 vaccine reminders

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06603090
1R01AI182165 (U.S. NIH Grant/Contract)
AAAV0563-01

Details and patient eligibility

About

This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.

Full description

The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first season. Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages. Within each practice site, parents of eligible children will be randomized to receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2) COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care).

Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.

Enrollment

50,000 estimated patients

Sex

All

Ages

6 months to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Child that:

    • is 6 months-17 year-old children
    • due for both a COVID-19 and influenza vaccine
  • Receives care at study site

  • Language listed in electronic health record is English or Spanish

  • Has not opted out of text messages from practice

Exclusion criteria

  • Has opted out of text messages from practice
  • Language listed in electronic health record is not English or Spanish

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

50,000 participants in 4 patient groups

Text message influenza and COVID-19 vaccine reminders
Experimental group
Description:
Text message reminders for both influenza and COVID-19 vaccinations
Treatment:
Behavioral: Text message influenza and COVID-19 vaccine reminders
Text message influenza vaccine reminders
Experimental group
Description:
Text message reminders only for influenza vaccination
Treatment:
Behavioral: Text message influenza vaccine reminders
Text message COVID-19 vaccine reminders
Experimental group
Description:
Text message reminders only for COVID-19 vaccination
Treatment:
Behavioral: Text message COVID-19 vaccine reminders
Usual Care
No Intervention group
Description:
Usual care has no text message

Trial contacts and locations

4

Loading...

Central trial contact

Alex Fiks, MD MSCE; Melissa Stockwell, MD MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems